Literature DB >> 12705485

Interleukin (IL) 1beta and IL-10 gene polymorphism in chronic hepatitis C patients with normal or elevated alanine aminotransferase levels.

Z Abbas1, T Moatter.   

Abstract

OBJECTIVE: To evaluate the frequency of cytokine gene single nucleotide polymorphisms (SNP) of IL-1beta and IL-10 at promoter sites -115 and -1082 respectively and their association with hepatocellular injury as suggested by alanine aminotransferase (ALT) level.
METHODS: Fifty six patients (31 males, 25 females) positive for HCV antibody were studied. Their mean age was 37.5 +/- 12.0 years (range 16-62). Fifty one were HCV RNA positive; 14 had normal and 37 elevated ALT levels. Type 3 was the predominant genotype. For cytokine polymorphism DNA was extracted from the whole blood. After amplification with polymerase chain reaction, biallelic polymorphisms of IL-1beta at -115 and IL-10 at -1082 promotor site were determined using sequence specific oligonucleotide primers.
RESULTS: IL-1beta-15 C allele was present in 49 (87.5%) and -115 T in 30 (53.6%) patients. Genotype CC was present in 26 (46%), TC 23 in (42%), and TT in 07 (12%). IL-10 -1082 A allele was seen in 50 (89.3%) and -1082 G in 35 (62.5%). Genotype AG in 29 (52%), AA in 21(37%), and GG in 06 (11%). Though greater number of HCV RNA positive patients with normal ALT had IL-10 -1082 AG genotype (10 out of 14), no statistically significant difference could be found in the genotype profile of the above promoter sites of IL-1beta and IL-10 in patients with normal or elevated ALT.
CONCLUSION: IL-1beta-115 C and IL-10 -1082A are the more frequent alleles in our patients. Genotypes L-1beta -115 CC and TC, and IL-10 -1082AG and AA are common while -115 TT and -1082 GG are less common. Any effect of IL-1beta and IL-10 gene polymorphism on the degree of hepatocellular injury may not be apparent by the ALT levels.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12705485

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  8 in total

Review 1.  Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.

Authors:  Rosa Zampino; Aldo Marrone; Luciano Restivo; Barbara Guerrera; Ausilia Sellitto; Luca Rinaldi; Ciro Romano; Luigi E Adinolfi
Journal:  World J Hepatol       Date:  2013-10-27

2.  Polymorphisms of some cytokines and chronic hepatitis B and C virus infection.

Authors:  Qiu-Ju Gao; Dian-Wu Liu; Shi-Yong Zhang; Min Jia; Li-Min Wang; Li-Hong Wu; Shu-Yun Wang; Li-Xin Tong
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

Review 3.  Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms.

Authors:  Luigi E Adinolfi; Rosa Zampino; Luciano Restivo; Amedeo Lonardo; Barbara Guerrera; Aldo Marrone; Fabio Nascimbeni; Anna Florio; Paola Loria
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

4.  Dysfunction of Immune Systems and Host Genetic Factors in Hepatitis C Virus Infection with Persistent Normal ALT.

Authors:  Yasuteru Kondo; Yoshiyuki Ueno; Tooru Shimosegawa
Journal:  Hepat Res Treat       Date:  2011-06-14

5.  Three polymorphisms in the IL-10 gene and the risk of HCV infection: a meta-analysis plus a Chinese Association Study involving 1140 subjects.

Authors:  J Li; Y Liu; F Xu; J Chen; Y Chen
Journal:  Epidemiol Infect       Date:  2012-09-27       Impact factor: 4.434

6.  Association of Interleukin-1B gene Polymorphism with H. pylori infected Dyspeptic Gastric Diseases and Healthy Population.

Authors:  Furkhanda Kalsoom; Muhammad Shahid Mahmood; Tahir Zahoor
Journal:  Pak J Med Sci       Date:  2020 May-Jun       Impact factor: 1.088

7.  Effect of Functional Interleukin-10 Polymorphism on Pegylated Interferon-α Plus Ribavirin Therapy Response in Chronic Hepatitis C Virus Patients Infected With 3a Genotype in Pakistani Population.

Authors:  Muhammad Sohail Afzal; Sadia Anjum; Najam Us Sahar Sadaf Zaidi
Journal:  Hepat Mon       Date:  2013-06-08       Impact factor: 0.660

Review 8.  Atherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C Virus.

Authors:  Theodoros Voulgaris; Vassilios A Sevastianos
Journal:  Hepat Res Treat       Date:  2016-01-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.